Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Intensity-modulated Radiotherapy
100%
Prognostic Factors
100%
Recurrent Nasopharyngeal Carcinoma
100%
Re-irradiation
100%
Overall Survival
50%
Tumor Volume
50%
Gross Tumor Volume
50%
Fractional Dose
50%
Mean Dose
33%
Local Recurrence
16%
Patient Survival
16%
Clinical Significance
16%
Disease-free Survival
16%
Multivariate Analysis
16%
Dose Volume
16%
5-year Survival
16%
Retrospective Analysis
16%
Small Tumor
16%
Cisplatin-based Chemotherapy
16%
Independent Prognostic Factor
16%
Univariate Analysis
16%
Young Patients
16%
Restaging
16%
Nasopharyngeal Carcinoma
16%
Distant Metastasis-free Survival
16%
Local Tumor Control
16%
N Stage
16%
Local Recurrence-free Survival
16%
Salvage Re-irradiation
16%
Disease Distribution
16%
Medicine and Dentistry
Intensity Modulated Radiation Therapy
100%
Prognostic Factor
100%
Nasopharynx Carcinoma
100%
Re-Irradiation
100%
Tumor
100%
Overall Survival
66%
Diseases
16%
Cancer Staging
16%
Recurrent Disease
16%
Cisplatin
16%
Disease Free Survival
16%
Univariate Analysis
16%
Distant Metastasis Free Survival
16%
Local Recurrence Free Survival
16%
Multivariate Analysis
16%
Biochemistry, Genetics and Molecular Biology
Overall Survival
100%
Tumor Volume
75%
Gross Tumor Volume
75%
Multivariate Analysis
25%
Cisplatin
25%
Local Recurrence Free Survival
25%
Distant Metastasis Free Survival
25%
Disease Free Survival
25%
Pharmacology, Toxicology and Pharmaceutical Science
Nasopharynx Carcinoma
100%
Overall Survival
80%
Diseases
20%
Recurrent Disease
20%
Chemotherapy
20%
Cisplatin
20%
Cancer Staging
20%
Disease Free Survival
20%
Distant Metastasis Free Survival
20%
Local Recurrence Free Survival
20%